The IQ Analytics Platform: Amyloid-IQ, Tau-IQ and Dat-IQ

Presenter: Roger Gunn, Ph.D. | Chief Scientific Officer, Neuroscience, Invicro

The IQ analytics platform uses spatial-temporal modelling of big imaging data sets, spanning the trajectory from health to disease, in order to extract salient canonical images providing a parsimonious representation of the imaging biomarkers signal. These canonical images are then embedded in an IQ algorithm so that they can optimally quantify the level of the target pathology. The IQ Algorithms have shown increased power and performance over the methods that are currently used to quantify clinical trial imaging data.

In this webinar, the presenter will review:

  1. How AmyloidIQ delivers increased power & performance for Alzheimer’s Disease clinical trials
  2. How TauIQ delivers increased power & performance for Alzheimer’s Disease clinical trials
  3. How DATIQ delivers increased power & performance for Parkinson’s Disease clinical trials

Register for On-Demand Access:
Roger-Gunn-1

ROGER GUNN, PH.D.

Chief Scientific Officer, Neuroscience, Invicro

Dr. Gunn is an international expert on imaging for disease understanding and drug development. He holds a Ph.D. in Applied Mathematics from Warwick University and has worked across Academia at Imperial College London, Oxford University, and  McGill University. Dr. Gunn has held numerous roles in Industry at GlaxoSmithKline (GSK) and Imanova. He has also held positions within government labs, including the MRC Cyclotron Unit. Dr. Gunn has made significant contributions to the development of novel imaging biomarkers, quantitative algorithms and software for a wide-range of imaging applications with a focus on the neurosciences. He currently holds faculty appointments at Imperial College London and Oxford University and has 200+ publications in the field of imaging.

© 2021 Invicro. All rights reserved.